Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women
This study has been completed.
Sponsor:
GlaxoSmithKline
Collaborator:
MedImmune LLC
Information provided by:
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00689741
First received: May 30, 2008
Last updated: NA
Last verified: May 2008
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | April 2003 |
| Primary Completion Date: | April 2003 (Final data collection date for primary outcome measure) |